Systemic lupus erythematosis.

57
SYSTEMIC LUPUS ERYTHEMATOSIS

Transcript of Systemic lupus erythematosis.

Page 1: Systemic lupus erythematosis.

SYSTEMIC LUPUS ERYTHEMATOSIS

Page 2: Systemic lupus erythematosis.

INTRODUCTION 

Page 3: Systemic lupus erythematosis.

DEFINITION

SLE is a chronic multisystem inflammatory disease of autoimmune in origin

Page 4: Systemic lupus erythematosis.

INCIDENCE

More women are affected than men

Page 5: Systemic lupus erythematosis.

ETIOLOGY

Viral infection Genetic factors bacterial infection drugs, (Sulpha drugs hydralazine

procainamide) Purperium Exposure to sunlight, sun burns Hormones

Page 6: Systemic lupus erythematosis.

PATHOPHYSIOLOGY

Page 7: Systemic lupus erythematosis.

CLINICAL MANIFESTATIONS

Skin Butterfly-shaped rash Discoid lesions are ring-shaped Discoid lesions may also result in

erythematous, scaly plaques

Page 8: Systemic lupus erythematosis.

ARTHRITIS:

Generally bilateral and symmetric,. Can resemble RA Unlike RA, the arthritis is non erosive;. Tendon involvement is common

Page 9: Systemic lupus erythematosis.

CARDIAC

Pericarditis. Pleural effusion. Myocarditis. Endocarditis. Coronary arteritis—less common.

Page 10: Systemic lupus erythematosis.

PULMONARY:

Pleuritis. Pleural effusion. Lupus pneumonitis. Pulmonary hemorrhage. Pulmonary embolism.

Page 11: Systemic lupus erythematosis.

GASTROINTESTINAL.

Oral ulcers. Acute or sub acute abdominal pain. Pancreatitis. Spontaneous bacterial peritonitis. Bowel infarction.

Page 12: Systemic lupus erythematosis.

RENAL:

Nephritis. Focal segmental glomerulonephritis Proliferative Membranous nephritis

Page 13: Systemic lupus erythematosis.

CENTRAL NERVOUS SYSTEM:

Neuropsychiatric disorders. Depression Psychosis. Transient ischemic attacks/stroke. Epilepsy. Migraine headache. Myleopathy. Guillain-Barre syndrome. Chorea and other movement disorders.

Page 14: Systemic lupus erythematosis.

HEMATOLOGIC:

Hemolytic anemia. Leucopenia. Thrombocytopenia

Page 15: Systemic lupus erythematosis.

CONSTITUTIONAL:

Fever. Weight loss. Fatigue.

Page 16: Systemic lupus erythematosis.

DIAGNOSTIC EVALUATION

CBC ESR Complement levels Urinalysis 24-hour urine for protein and creatinine clearance. Chest x-ray Computed tomography (CT) scan or MRI.

Page 17: Systemic lupus erythematosis.

MANAGEMENT

Pharmacologic NSAIDs—to reduce pain and inflammation. Antimalarials—to decrease disease activity. Corticosteroids—to reduce inflammatory

process. Immunosuppressive—to suppress immune

process

Page 18: Systemic lupus erythematosis.

NON PHARMACOLOGIC

Avoid direct exposure to sunlight to reduce the chance of exacerbation.

Behavior modification to prevent exacerbations and to reduce symptoms.

Joint protection and energy conservation.

Page 19: Systemic lupus erythematosis.

OTHER MANAGEMENT

Close follow-up for evaluation of cardiac, neurologic, renal, and other body systems.

Referral to specialists for systemic manifestations.

Page 20: Systemic lupus erythematosis.

NURSING ASSESSMENT

Obtain clinical history, review systems, and perform physical examination for characteristic findings.

Assess for signs and symptoms of infection and other side effects to medications.

Assess patient's and family's ability to cope with impact of prolonged disease.

Page 21: Systemic lupus erythematosis.

NURSING DIAGNOSES

Fatigue related to chronic inflammation and altered immunity as evidenced by lack of energy inability to maintain usual routine

Acute pain related to inflammatory process and inadequate comfort measures as evidenced by complaints of joint pain lack of relief from pain relieving measures ,reduction of activity to avoid exacerbation of pain

Page 22: Systemic lupus erythematosis.

Impaired skin integrity related to photosensitivity ,skin rash ,and alopecia as evidenced by rash anywhere on body butterfly rash on face hairless areas of ulceration on fingertips, complaints of urticaria and photosensitivity

Knowledge deficit related to lack of exposure to and unfamiliarity with information resources as evidenced by questions about SLE misinterpretation of information and inaccurate follow -through of instruction

Page 23: Systemic lupus erythematosis.

NURSING INTERVENTIONS REDUCING PAIN

Administer and teach self-administration of medications

use of hot or cold applications, relaxation techniques

Page 24: Systemic lupus erythematosis.

INCREASING CONTROL OVER DISEASE PROCESS Instruct patient to avoid factors that may

exacerbate disease. Avoid exposure to sunlight and ultraviolet light. Use sunscreen with sun protection factor (SPF)of

15 or greater. Avoid prolonged sun exposure. Wear protective, lightweight clothing, long

sleeves, hats. Avoid use of tanning beds. Avoid exposure to drugs and chemicals. Avoid exposure to hair spray Avoid exposure to hair-coloring agents.

Page 25: Systemic lupus erythematosis.

MEDICATIONS

Teach self-administration of pharmacologic agents to reduce disease activity.

Encourage good nutrition, sleep habits, exercise, rest, and relaxation to improve general health and to help prevent infection.

Encourage ventilation of feelings, counseling, or referrals to social work, occupational therapy, as needed.

Page 26: Systemic lupus erythematosis.

MAINTAINING SKIN AND MUCOUS MEMBRANE INTEGRITY

Apply topical corticosteroids to skin lesions as ordered.

Suggest alternative hairstyles, scarves, and wigs to cover significant areas of alopecia.

Encourage good oral hygiene and inspect mouth for oral ulcers.

Avoid hot or spicy foods that may irritate oral ulcers.

Apply topical agents or analgesics to reduce pain andto promote eating.

Page 27: Systemic lupus erythematosis.

REDUCING FATIGUE

Advise patient that fatigue level will fluctuate with disease activity.

Encourage patient to modify schedule to include several rest periods during the day, pace activity and exercise according to body's tolerance, use energy conservation techniques in daily activities.

Teach relaxation techniques, such as deep breathing, progressive muscle relaxation, and imagery to reduce emotional stress that causes fatigue.

Page 28: Systemic lupus erythematosis.

PRESERVING URINARY ELIMINATION

Assist with monitoring of urinary status as indicated by degree of renal involvement.

Monitor intake and output and urine specific gravity.

Measure urine protein, micro albumin, or obtain24-hour creatinine clearance, as ordered.

Check test results of serum blood urea nitrogen (BUN) and creatinine.

Page 29: Systemic lupus erythematosis.

PATIENT EDUCATION AND HEALTH MAINTENANCE

Stress that close follow-up is mandatory, even in times of remission, to detect early progression of organ involvement and to alter drug therapy.

Advise on the use of special cosmetics to cover skin lesions.Advise about reproduction.

Avoid pregnancy during time of severe disease activity.

Immunomodulators may have teratogenic effects.

Use of some drugs for treatment of SLE can result instability.

Page 30: Systemic lupus erythematosis.

COMPLICATIONS

Renal failure. Permanent neurologic impairment. Infection.

Page 31: Systemic lupus erythematosis.

GOUT

Page 32: Systemic lupus erythematosis.

INTRODUCTION

Page 33: Systemic lupus erythematosis.

DEFINITION

Gout is a disorder of purine metabolism characterized by elevated uric acid levels and deposition of urate in joints and other tissues

Page 34: Systemic lupus erythematosis.

INCIDENCE

more commonly in men, middle aged men are more affected

Page 35: Systemic lupus erythematosis.

ETIOLOGY

Common causes Under excretion of uric acid Medications and chemicals

Page 36: Systemic lupus erythematosis.

COMMON CAUSES

Inherited enzyme defects. Certain disease conditions: Myelo proliferative disorders. Lymphoproliferative disorders. Cancer chemotherapy. Hemolytic anemias. Psoriasis.

Page 37: Systemic lupus erythematosis.

UNDER EXCRETION OF URIC ACID (90% OF CASES)

Renal disease. Endocrine disorders

Page 38: Systemic lupus erythematosis.

MEDICATIONS AND CHEMICALS:

Diuretics. Ethanol (alcohol). Low-dose aspirin. Pyrazinamide— anti tuberculosis agent. Lead. Volume depletion states—nephrogenic

diabetes insipidus.

Page 39: Systemic lupus erythematosis.

PATHOPHYSIOLOGY

Uric acid is the major end product of purine catabolism and is primarily excreted by the kidneys hyperuricemia may be result of of increased purine synthesis decreased renal excretion or both, Gout results from an overabundant accumulation and subsequent deposition of uric acid in the body.

Page 40: Systemic lupus erythematosis.

CLINICAL MANIFESTATIONS ACUTE GOUTY ARTHRITIS

Generally affects one joint—often first metatarso phalangeal joint

Other joints can be affected, such as ankle, knee; upper extremities are less commonly involved.

Pain, warmth, erythema, and swelling of tissue surrounding the affected joint.

Fever may occur. Onset of symptoms is sudden; intensity is

severe. Duration of symptoms is self-limiting; lasts

approxi mately 3 to 10 days without treatment

Page 41: Systemic lupus erythematosis.

CHRONIC TOPHACEOUS GOUT

Occurs if acute gout is inadequately treated or if it goes untreated.

Characterized by development of tophi or deposits of uric acid in and around joints, cartilage, and soft tissues.

Arthritis is more prolonged in nature with discrete attacks less common.

Page 42: Systemic lupus erythematosis.

RENAL DISEASE

Caused by hyperuricemia (persistent elevation of uric acid in the blood).

Kidney stones are composed of uric acid. Deposition of uric acid in kidney tissue.

Page 43: Systemic lupus erythematosis.

DIAGNOSTIC EVALUATION

Synovial fluid analysis. Identification of monosodium urate crystals

under polarized microscopy. Synovial WBC count can range from 2,000 to

100,000/mm3. Culture of synovial fluid to rule out infection. 24-hour urine for uric acid to determine

overproduction of uric acid versus under excretion.

ESR—elevated. X-rays of affected joints show changes

consistent with diagnosis of gout.

Page 44: Systemic lupus erythematosis.

PHARMACOLOGIC MANAGEMENT

NSAIDs—for acute attacks to relieve pain and swelling.

Colchicines—for prevention of acute attacks and their treatment.

Oral at onset of an attack, taken hourly until pain relief or first signs of toxicity (nausea, vomiting ,cramping, diarrhea

Page 45: Systemic lupus erythematosis.

CORTICOSTEROIDS.

Intra-articular if attack confined to one joint. Oral—in short tapering course if other

treatmentsare contraindicated or if attack involves many joints.

Page 46: Systemic lupus erythematosis.

URATE-LOWERING AGENTS

Uricosuric drugs, such as probenecid (Benamid), inter fere with

tubular reabsorption of uric acid. Allopurinol (Zyloprim)—interferes with

conversion of hypoxanthine and xanthine to uric acid.

Page 47: Systemic lupus erythematosis.

NONPHARMACOLOGIC

Avoidance of obesity. Avoidance of alcohol. Low-purine diet gives only a minor decrease

in serum uric acid levels.

Page 48: Systemic lupus erythematosis.

NURSING ASSESSMENT

Obtain history for factors predisposing to gout.

Perform physical examination. Inspect involved joint. Observe for tophi:a) Pinna of ear. b) Olecranon bursa c) Achilles tendon. Assess pain and pain relief pattern if attack is

acute

Page 49: Systemic lupus erythematosis.

NURSING INTERVENTIONS RELIEVING PAIN

Administer and teach self-administration of pain relieving medications as prescribed.

Encourage adequate fluid intake to assist with excretion of uric acid and to decrease likelihood of stone formation.

Instruct patient to take prescribed medications consis tently because interruptions in therapy can precipitate acute attacks.

Page 50: Systemic lupus erythematosis.

FACILITATING MOBILITY

Elevate and protect affected joint during acute attack.

Assist with activities of daily living. Encourage exercise and maintenance of

routine activity in chronic gout, except during acute attacks.

Protect draining tophi by covering and applying anti biotic ointment as needed.

Page 51: Systemic lupus erythematosis.

PATIENT EDUCATION

Instruct patient and family about nature of disease.

Encourage to avoid alcohol. Avoid rapid weight loss by fasting or crash Avoid medications known to increase uric

acid levels. Advise prompt treatment of acute attack Instruct in signs and symptoms of allopurinol

hyper sensitivity Review foods containing purine

Page 52: Systemic lupus erythematosis.

COMPLICATIONS

Uric acid kidney stone. Urate nephropathy. deforming arthritis

Page 53: Systemic lupus erythematosis.

SIDE EFFECTS OF TREATMENT

Include skin rash hypersensitivity syndrome renal failure bone marrow depression

Page 54: Systemic lupus erythematosis.

EVIDENCE BASED RESEARCH

Page 55: Systemic lupus erythematosis.

CONCLUSION

Page 56: Systemic lupus erythematosis.

BIBLIOGRAPHY

Page 57: Systemic lupus erythematosis.

Thank you